272 related articles for article (PubMed ID: 28212680)
1. MeCP2 mutations: progress towards understanding and treating Rett syndrome.
Shah RR; Bird AP
Genome Med; 2017 Feb; 9(1):17. PubMed ID: 28212680
[TBL] [Abstract][Full Text] [Related]
2. Regulation mechanism and research progress of MeCP2 in Rett syndrome.
Yang W; Pan H
Yi Chuan; 2014 Jul; 36(7):625-30. PubMed ID: 25076025
[TBL] [Abstract][Full Text] [Related]
3. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
[TBL] [Abstract][Full Text] [Related]
4. Evolving role of MeCP2 in Rett syndrome and autism.
LaSalle JM; Yasui DH
Epigenomics; 2009 Oct; 1(1):119-30. PubMed ID: 20473347
[TBL] [Abstract][Full Text] [Related]
5. Rett syndrome and MeCP2.
Liyanage VR; Rastegar M
Neuromolecular Med; 2014 Jun; 16(2):231-64. PubMed ID: 24615633
[TBL] [Abstract][Full Text] [Related]
6. MeCP2 dysfunction in Rett syndrome and related disorders.
Moretti P; Zoghbi HY
Curr Opin Genet Dev; 2006 Jun; 16(3):276-81. PubMed ID: 16647848
[TBL] [Abstract][Full Text] [Related]
7. Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation.
Jentarra GM; Olfers SL; Rice SG; Srivastava N; Homanics GE; Blue M; Naidu S; Narayanan V
BMC Neurosci; 2010 Feb; 11():19. PubMed ID: 20163734
[TBL] [Abstract][Full Text] [Related]
8. Ocular MECP2 protein expression in patients with and without Rett syndrome.
Jain D; Singh K; Chirumamilla S; Bibat GM; Blue ME; Naidu SR; Eberhart CG
Pediatr Neurol; 2010 Jul; 43(1):35-40. PubMed ID: 20682201
[TBL] [Abstract][Full Text] [Related]
9. Towards a better diagnosis and treatment of Rett syndrome: a model synaptic disorder.
Banerjee A; Miller MT; Li K; Sur M; Kaufmann WE
Brain; 2019 Feb; 142(2):239-248. PubMed ID: 30649225
[TBL] [Abstract][Full Text] [Related]
10. Metabolic fingerprints of altered brain growth, osmoregulation and neurotransmission in a Rett syndrome model.
Viola A; Saywell V; Villard L; Cozzone PJ; Lutz NW
PLoS One; 2007 Jan; 2(1):e157. PubMed ID: 17237885
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol metabolism and Rett syndrome pathogenesis.
Nagy G; Ackerman SL
Nat Genet; 2013 Sep; 45(9):965-7. PubMed ID: 23985682
[TBL] [Abstract][Full Text] [Related]
12. Severe offtarget effects following intravenous delivery of AAV9-MECP2 in a female mouse model of Rett syndrome.
Matagne V; Borloz E; Ehinger Y; Saidi L; Villard L; Roux JC
Neurobiol Dis; 2021 Feb; 149():105235. PubMed ID: 33383186
[TBL] [Abstract][Full Text] [Related]
13. Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with bone disease severity in Rett syndrome.
Caffarelli C; Gonnelli S; Pitinca MDT; Camarri S; Al Refaie A; Hayek J; Nuti R
BMC Med Genet; 2020 Jan; 21(1):21. PubMed ID: 32005172
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of lethal cardiac arrhythmias in Mecp2 mutant mice: implication for therapy in Rett syndrome.
McCauley MD; Wang T; Mike E; Herrera J; Beavers DL; Huang TW; Ward CS; Skinner S; Percy AK; Glaze DG; Wehrens XH; Neul JL
Sci Transl Med; 2011 Dec; 3(113):113ra125. PubMed ID: 22174313
[TBL] [Abstract][Full Text] [Related]
15. The role of MeCP2 in brain development and neurodevelopmental disorders.
Gonzales ML; LaSalle JM
Curr Psychiatry Rep; 2010 Apr; 12(2):127-34. PubMed ID: 20425298
[TBL] [Abstract][Full Text] [Related]
16. A methyl-CpG-binding protein 2-enhanced green fluorescent protein reporter mouse model provides a new tool for studying the neuronal basis of Rett syndrome.
Schmid RS; Tsujimoto N; Qu Q; Lei H; Li E; Chen T; Blaustein CS
Neuroreport; 2008 Mar; 19(4):393-8. PubMed ID: 18287934
[TBL] [Abstract][Full Text] [Related]
17. The story of Rett syndrome: from clinic to neurobiology.
Chahrour M; Zoghbi HY
Neuron; 2007 Nov; 56(3):422-37. PubMed ID: 17988628
[TBL] [Abstract][Full Text] [Related]
18. Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome.
Urdinguio RG; Fernandez AF; Lopez-Nieva P; Rossi S; Huertas D; Kulis M; Liu CG; Croce CM; Calin GA; Esteller M
Epigenetics; 2010 Oct; 5(7):656-63. PubMed ID: 20716963
[TBL] [Abstract][Full Text] [Related]
19. MECP2 mutations in Serbian Rett syndrome patients.
Djarmati A; Dobricić V; Kecmanović M; Marsh P; Jancić-Stefanović J; Klein C; Djurić M; Romac S
Acta Neurol Scand; 2007 Dec; 116(6):413-9. PubMed ID: 17986102
[TBL] [Abstract][Full Text] [Related]
20. BDNF deregulation in Rett syndrome.
Li W; Pozzo-Miller L
Neuropharmacology; 2014 Jan; 76 Pt C(0 0):737-46. PubMed ID: 23597512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
